DRUG

bergapten

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for bergapten

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid novel signal none

Clinical trials

2 registered trials for bergapten

Source: ClinicalTrials.gov